Medline Q2 Adj. EPS $0.50 Beats $0.32 Estimate, Sales $7.685B Beat $7.512B Estimate

Benzinga Newsdesk www.benzinga.com Positive 87.8%

Neg 0% Neu 0% Pos 87.8%

Medline (NASDAQ:MDLN) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.32 by 56.25 percent. The company reported quarterly sales of $7.685 billion which beat the analyst consensus estimate of $7.512 billion by 2.30 percent.